Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Caeregen Therapeutics, a regenerative medicine therapeutics company and Wacker Biotech, a contract development and manufacturing organization (CDMO), will collaborate on the development and production of CTR-107 (Noregen™), a novel regenerative ...
read more
Caisson Biotech, a provider of half-life extension and drug delivery platforms, has established a global manufacturing partnership with CordenPharma International, a full-service Contract Development & Manufacturing Organization (CDMO) manufacturing ...
read more
CalAmp has announced a collaboration with Cryoport to develop a next generation condition monitoring system to further assure the security of global temperature controlled pharmaceutical shipments.
read more
Rockwell Medical provided an update regarding Calcitriol, the company's FDA approved active vitamin D injection for the management of hypocalcemia in patients undergoing chronic hemodialysis.
read more
SACRAMENTO, Calif. (AP) — California lawmakers on Tuesday approved a hotly contested bill that would impose one of the strictest vaccination laws in the country, after five hours of highly emotional testimony that brought hundreds of opponents to the...
read more
AGC Biologics produces a GMP-grade clinical batch of CALY-002 for Calypso Biotech.
read more
Thursday, February 11, 2021
Calyx announced an expansion to its Executive Leadership Team. Richard Wallace joins Calyx as Chief Digital and Information Officer (CDIO).
read more
Calyx, an eClinical and Regulatory solutions and services provider announced the availability of Calyx Supply Simulation, a clinical trial supply forecasting service available through Calyx's in-house expert statistical design and trial supplies ...
read more
Wednesday, March 03, 2021
Camargo Pharmaceutical Services will acquire Paidion Research, a global pediatric CRO based in Durham, N.C.
read more
Thursday, February 28, 2013
Camargo Pharmaceutical Services, the 505(b)(2) experts, is teaming with XenoTech, a leading contract research organization in the drug metabolism field, to present a webinar March 21 for drug developers who want to learn how to use the 505(b)(2) ...
read more
Thursday, October 31, 2013
The U.S. regulatory landscape changed dramatically 10 years ago. In 2003, legal roadblocks to the 505(b)(2) approval pathway were resolved, making it a practical alternative route for drug development. That same year, Ken Phelps and Ruth Stevens ...
read more
The U.S. regulatory landscape has changed dramatically in 10 years. In 2003, the FDA finally resolved legal hurdles to the 505(b)(2) approval pathway, making it a practical alternative route for drug development. The same year, Ken Phelps and Ruth ...
read more
Monday, February 09, 2015
Camargo Pharmaceutical Services, a leading drug development organization specializing in the 505(b)(2) approval pathway, will reveal its new brand at the Generic Pharmaceutical Association (GPhA) Annual Meeting. The new brand comes as 505(b)(2) is ...
read more
Wednesday, March 02, 2016
Xpertdoc Technologies Inc., a Microsoft Gold Partner and a document generation and customer communications solutions provider, has announced that Camargo Pharmaceutical Services has selected Xpertdoc’s CCM platform and Microsoft Dynamics CRM ...
read more
Camargo Pharmaceutical Services has received a significant growth investment from a private non-institutional investment firm.
read more